This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Sumitomo Chemical's trademark rights upheld by Indian Court

By Freny Patel ( July 7, 2025, 00:06 GMT | Insight) -- Sumitomo Chemical Company has emerged victorious in a trademark dispute after the Delhi High Court dismissed a suit filed by Coromandel Indag Products India Ltd., citing lack of legal standing. The court ruled that Coromandel Indag had no enforceable rights over the "PADAN" trademark, which it claimed had been infringed. Instead, the court found that the trademark rights were held by Coromandel Agriscience, a separate legal entity currently undergoing insolvency proceedings. As CAPL was not a party to the case and only its resolution professional could bring such a suit, the court concluded that Coromandel Indag had no authority to initiate the legal action, effectively rendering the suit untenable.Sumitomo Chemical Company has won a legal battle after an Indian court dismissed a trademark suit filed by Coromandel Indag Products India for want of legal standing....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections